![Roberto Díez-Martínez](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Roberto Díez-Martínez
Directeur Général chez Ikan Biotech SL
Postes actifs de Roberto Díez-Martínez
Sociétés | Poste | Début | Fin |
---|---|---|---|
Ikan Biotech SL
![]() Ikan Biotech SL BiotechnologyHealth Technology Ikan Biotech SL engages in the design and development of xenograft models. Its Xenograft Model is a tumour model system to design and test the efficacy of potential drugs for the treatment of cancer. The company was founded by Rubén Díez Punzano and Roberto Díez-Martínez on April 7, 2015 and is headquartered in Noáin, Spain. | Directeur Général | - | - |
Fondateur | 07/04/2015 | - | |
Directeur Technique/Scientifique/R&D | 07/04/2015 | - | |
Telum Therapeutics SL
![]() Telum Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Telum Therapeutics SL is a Spanish biotechnology company that specializes in drug discovery and the use of Innovative Phage Lytic Proteins as antibiotics. The company is based in Noáin, Spain. The company has specific programs to treat serious multidrug-resistant Gram-negative infections caused by Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa. Telum Therapeutics leverages the power of nature through the understanding of biological controls exerted by bacteriophages to balance bacterial ecosystems. The CEO of the company is Roberto Díez-Martínez. | Directeur/Membre du Conseil | - | - |
Directeur des opérations | 19/03/2024 | - | |
Directeur Général | - | 19/03/2024 |
Historique de carrière de Roberto Díez-Martínez
Statistiques
Internationale
Espagne | 3 |
Opérationnelle
Chief Executive Officer | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectorielle
Health Technology | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Ikan Biotech SL
![]() Ikan Biotech SL BiotechnologyHealth Technology Ikan Biotech SL engages in the design and development of xenograft models. Its Xenograft Model is a tumour model system to design and test the efficacy of potential drugs for the treatment of cancer. The company was founded by Rubén Díez Punzano and Roberto Díez-Martínez on April 7, 2015 and is headquartered in Noáin, Spain. | Health Technology |
Telum Therapeutics SL
![]() Telum Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Telum Therapeutics SL is a Spanish biotechnology company that specializes in drug discovery and the use of Innovative Phage Lytic Proteins as antibiotics. The company is based in Noáin, Spain. The company has specific programs to treat serious multidrug-resistant Gram-negative infections caused by Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa. Telum Therapeutics leverages the power of nature through the understanding of biological controls exerted by bacteriophages to balance bacterial ecosystems. The CEO of the company is Roberto Díez-Martínez. | Commercial Services |
- Bourse
- Insiders
- Roberto Díez-Martínez
- Expérience